Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat
about
Dysregulation of glutathione homeostasis in neurodegenerative diseasesPharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophreniaGlutathione deficiency leads to mitochondrial damage in brainA review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxinsTargeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain.Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristicsAstrocytes and therapeutics for Parkinson's disease.Oral antioxidant therapy for juvenile rats with kaolin-induced hydrocephalusAnimal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacologyDevelopment and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker.Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease.Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems.Differential receptor-mediated drug targeting to the diseased brain.Strategies to target drugs to gliomas and CNS metastases of solid tumors.Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.GSH transporters: molecular characterization and role in GSH homeostasis.GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter.Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain strokeThe effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock.In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. Expression of bovine brain capillary mRNA and size fractions in Xenopus laevis oocytes and dissociation from gamma-glutamyltranspeptidase and facilitative GSH transporteThe Role of Gut Microbiome and Associated Metabolome in the Regulation of Neuroinflammation in Multiple Sclerosis and Its Implications in Attenuating Chronic Inflammation in Other Inflammatory and Autoimmune Disorders.Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters.Glutathione: Antioxidant Properties Dedicated to Nanotechnologies.
P2860
Q26822726-288AB39E-BED9-4CE4-BD45-CAD65B6A547BQ27300391-B0C0E01F-678E-47CF-84A4-8CBA4F4EB9B7Q28248687-9E56AEF2-E92C-4074-AFFC-3D6A04E8D2CEQ28267318-9B5FB44C-9348-4B45-A5D6-52C51EE60E57Q28382991-5DA42F8A-06B8-43DC-82CE-9FED365D18CFQ30406070-71CBEFDB-4AC2-45B7-8815-F7C77499C61FQ33874423-14BC263E-A4A6-4D55-96CB-33AAAEADC46EQ34141503-EAFBBA10-D675-4101-9B99-E6C9D7F8AA0FQ34168266-CFBADFC7-F1F7-41F6-8EF9-AD58464F0887Q34352465-1C09B812-2851-475F-A8E1-60C253CF5B09Q34541077-0D72F611-76A0-4B03-9D8E-15575365E0A5Q34756512-9D68962C-B9CD-430A-B0D0-A51E380CD842Q35728704-2B8458BD-F6AA-48C4-8DAE-D75DB707AAE1Q36023685-E48372D5-0404-48AE-9899-CA70E5FBC90AQ37425213-59E33CCA-DB08-4BE2-88F1-83712483F119Q38610113-28B95133-59CE-4AC9-AD36-9EF1B33B78F9Q39024233-81F79609-6551-4DF4-BD8B-07DB2EBD628EQ40940194-B4EE034E-08F9-43E9-8722-D6C21B9655FAQ40945043-8837DC72-9C60-4A1B-BADB-EDA6AB3FE3E4Q41961874-CFDF382A-7BD4-4A2C-B272-192F44AA02EEQ43948790-3F4745A4-9BE7-494A-8947-9B3FE41D1C2FQ44331420-DCA20BB5-07AE-48B7-8B54-5E3C46B075F6Q46426150-EE3FE57C-F496-4627-B4AE-4EDE4562B692Q47824376-2B067658-DEB7-4016-A996-81EF1A3B2DBDQ47828871-6CB5114F-5A46-449D-9F64-79145890B5BFQ48505892-D28EAD4C-88CE-4ED5-97A1-75E90E9C6069Q48642775-27ABA4BD-B78E-4CE8-9250-AA7AAA6E7AE4Q55001140-0CA4096D-EE71-4DA0-AB36-384FFB5C8557
P2860
Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@ast
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@en
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@nl
type
label
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@ast
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@en
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@nl
prefLabel
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@ast
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@en
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@nl
P2093
P2860
P356
P1476
Evidence for carrier-mediated ...... blood-brain barrier in the rat
@en
P2093
E Jeandidier
J F Kuhlenkamp
M Ookhtens
N Kaplowitz
P2860
P304
P356
10.1172/JCI114666
P407
P577
1990-06-01T00:00:00Z